Thackray Alana M, Andréoletti Olivier, Bujdoso Raymond
Department of Veterinary Medicine, University of Cambridge, Cambridge, CB3 OES, UK.
UMR INRA ENVT 1225 -Hôtes-Agents Pathogènes, Ecole Nationale Vétérinaire de Toulouse, Toulouse, 31076, France.
F1000Res. 2018 May 15;7:595. doi: 10.12688/f1000research.14753.1. eCollection 2018.
Prion diseases are fatal neurodegenerative conditions of humans and vertebrate species. The transmissible prion agent is a novel infectious particle composed principally of PrP , an abnormal isomer of the normal host protein PrP . The only reliable method to detect mammalian prion infectivity is by bioassay, invariably in a vertebrate host. The current prion bioassays typically involve intracerebral or peripheral inoculation of test material into the experimental host and subsequent euthanasia when clinical signs of terminal prion disease become evident. It may be months or years before the onset of clinical disease becomes evident and a pre-determined clinical end-point is reached. Consequently, bioassay of prion infectivity in vertebrate species is cumbersome, time consuming, expensive, and increasingly open to ethical debate because these animals are subjected to terminal neurodegenerative disease. Prions are a significant risk to public health through the potential for zoonotic transmission of animal prion diseases. Attention has focussed on the measurement of prion infectivity in different tissues and blood from prion-infected individuals in order to determine the distribution of infectious prions in diseased hosts. New animal models are required in order to replace or reduce, where possible, the dependency on the use of vertebrate species, including the 'gold standard' mouse prion bioassay, to assess prion infectivity levels. Here we highlight the development of a -based prion bioassay, a highly sensitive and rapid invertebrate animal system that can efficiently detect mammalian prions. This novel invertebrate model system will be of considerable interest to biologists who perform prion bioassays as it will promote reduction and replacement in the number of sentient animals currently used for this purpose. This article is a composite of previous methods that provides an overview of the methodology of the model and discusses the experimental data to promote its viability for use instead of more sentient hosts.
朊病毒疾病是人类和脊椎动物的致命神经退行性疾病。可传播的朊病毒病原体是一种新型感染性粒子,主要由PrP组成,它是正常宿主蛋白PrP的异常异构体。检测哺乳动物朊病毒感染性的唯一可靠方法是生物测定法,通常在脊椎动物宿主中进行。当前的朊病毒生物测定法通常包括将测试材料脑内或外周接种到实验宿主中,当终末期朊病毒疾病的临床症状明显时随后实施安乐死。可能要数月或数年临床疾病才会明显出现并达到预定的临床终点。因此,在脊椎动物物种中进行朊病毒感染性的生物测定既麻烦、耗时、昂贵,并且由于这些动物会患上终末期神经退行性疾病,越来越容易引发伦理争议。朊病毒通过动物朊病毒疾病人畜共患传播的可能性对公众健康构成重大风险。人们关注对朊病毒感染个体不同组织和血液中朊病毒感染性的测量,以确定患病宿主中感染性朊病毒的分布。需要新的动物模型,以便在可能的情况下替代或减少对脊椎动物物种的依赖,包括“金标准”小鼠朊病毒生物测定法,来评估朊病毒感染性水平。在此,我们重点介绍一种基于[具体内容未给出]的朊病毒生物测定法的开发,这是一种高度敏感且快速的无脊椎动物系统,能够有效检测哺乳动物朊病毒。这种新型无脊椎动物模型系统对于进行朊病毒生物测定的生物学家来说将具有极大的吸引力,因为它将有助于减少和替代目前用于此目的的有感知能力动物的数量。本文综合了先前的方法,概述了该模型的方法,并讨论了实验数据,以促进其替代更多有感知能力宿主使用的可行性。